Abacavir is a chiral purine carbocyclic nucleoside, which is a prodrug of the guanosine analog (-) carbovir, Abacavir or ABC is an antiretroviral medication used to prevent and treat HIV/AIDS. Reference standards of Abacavir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => abacavir impurity 1 (1114RB) [catalogue_number] => PA BP1114RB [category_ids] => ,153, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => abacavir-impurity-1-1114rb-pabp1114rb [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BP1114RB
CAS :
Molecular Formula : NA
Molecular Weight : NA
stdClass Object ( [pname] => abacavir impurity standard (1113RB) [catalogue_number] => PA BP1113RB [category_ids] => ,153, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => abacavir-impurity-standard-1113rb-pabp1113rb [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BP1113RB
stdClass Object ( [pname] => abacavir sulfate (1112RB) [catalogue_number] => PA BP1112RB [category_ids] => ,153, [chemical_name] => [weight] => NA [form] => NA [cas] => NA [pslug] => abacavir-sulfate-1112rb-pabp1112rb [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BP1112RB
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....